SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-19-006440
Filing Date
2019-04-03
Accepted
2019-04-03 17:13:46
Documents
2
Group Members
INTREXON CORPNRM VII HOLDINGS I, LLCTHIRD SECURITY, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A formsc13da.htm SC 13D/A 170727
2 EXHIBIT 1 ex99_1.htm EX-99.1 9871
  Complete submission text file 0001140361-19-006440.txt   182278
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Subject) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-50777 | Film No.: 19729988
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1881 GROVE AVENUE RADFORD VA 24141
Business Address
KIRK RANDAL J (Filed by) CIK: 0001091823 (see all company filings)

Type: SC 13D/A